Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Hayden

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Handbook of Experimental Pharmacology|December 28, 2020
Standardised Reconstructed Skin Models in Toxicology and Pharmacology: State of the Art and Future DevelopmentHelena Kandarova, Patrick J Hayden
In Vitro Cellular & Developmental Biology. Animal|November 25, 2020
Special review series on 3D organotypic culture models: Introduction and historical perspectivePatrick J Hayden, John W Harbell
Journal of Cosmetic Dermatology|June 10, 2014
DNA photoprotection conveyed by sunscreenCharlene DeHaven, Patrick J Hayden, Alexander Armento, et al.
British Journal of Haematology|April 2, 2024
Sequence not salvageDouglas W Sborov, Gliceida Galarza Fortuna, Patrick J Hayden
Expert Review of Hematology|June 24, 2016
Management of high-risk Myeloma: an evidence-based review of treatment strategiesNicola Lehners, Patrick J Hayden, Hartmut Goldschmidt, et al.
Applied in Vitro Toxicology|June 16, 2018
Prevalidation of an Acute Inhalation Toxicity Test Using the EpiAirway <i>In Vitro</i> Human Airway ModelGeorge R Jackson, Anna G Maione, Mitchell Klausner, et al.
The Cochrane Database of Systematic Reviews|April 21, 2016
Bortezomib for the treatment of multiple myelomaKathleen Scott, Patrick J Hayden, Andrea Will, et al.
Best Practice & Research. Clinical Haematology|December 12, 2007
From the bench to the bedside: emerging new treatments in multiple myelomaConstantine S Mitsiades, Patrick J Hayden, Kenneth C Anderson, et al.
Current Opinion in Hematology|September 28, 2007
Novel therapies in myelomaPatrick J Hayden, Constantine S Mitsiades, Kenneth C Anderson, et al.
Current Opinion in Oncology|August 3, 2020
Clinical data, limitations and perspectives on chimeric antigen receptor T-cell therapy in multiple myelomaDavid Beauvais, Sophia Danhof, Patrick J Hayden, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Handbook of Experimental Pharmacology|December 28, 2020
Standardised Reconstructed Skin Models in Toxicology and Pharmacology: State of the Art and Future DevelopmentHelena Kandarova, Patrick J Hayden
In Vitro Cellular & Developmental Biology. Animal|November 25, 2020
Special review series on 3D organotypic culture models: Introduction and historical perspectivePatrick J Hayden, John W Harbell
Journal of Cosmetic Dermatology|June 10, 2014
DNA photoprotection conveyed by sunscreenCharlene DeHaven, Patrick J Hayden, Alexander Armento, et al.
British Journal of Haematology|April 2, 2024
Sequence not salvageDouglas W Sborov, Gliceida Galarza Fortuna, Patrick J Hayden
Expert Review of Hematology|June 24, 2016
Management of high-risk Myeloma: an evidence-based review of treatment strategiesNicola Lehners, Patrick J Hayden, Hartmut Goldschmidt, et al.
Applied in Vitro Toxicology|June 16, 2018
Prevalidation of an Acute Inhalation Toxicity Test Using the EpiAirway <i>In Vitro</i> Human Airway ModelGeorge R Jackson, Anna G Maione, Mitchell Klausner, et al.
The Cochrane Database of Systematic Reviews|April 21, 2016
Bortezomib for the treatment of multiple myelomaKathleen Scott, Patrick J Hayden, Andrea Will, et al.
Best Practice & Research. Clinical Haematology|December 12, 2007
From the bench to the bedside: emerging new treatments in multiple myelomaConstantine S Mitsiades, Patrick J Hayden, Kenneth C Anderson, et al.
Current Opinion in Hematology|September 28, 2007
Novel therapies in myelomaPatrick J Hayden, Constantine S Mitsiades, Kenneth C Anderson, et al.
Current Opinion in Oncology|August 3, 2020
Clinical data, limitations and perspectives on chimeric antigen receptor T-cell therapy in multiple myelomaDavid Beauvais, Sophia Danhof, Patrick J Hayden, et al.
Pageof 8